Ceres Ventures, Revenue Growth Rates (CEVE), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Ceres Ventures, Inc.  (CEVE)
 

CEVE's Revenue Growth by Quarter and Year

Ceres Ventures,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CEVE Revenue (in millions $) FY 2012 FY 2011 FY 2010 FY 2009
4th Quarter December -
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 0.00





CEVE Revenue third quarter 2012 Y/Y Growth Comment
Ceres Ventures, Inc. in the third quarter 2012 recorded of $ 0.00 millions.

According to the results reported in the third quarter 2012, Ceres Ventures, Inc. achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Ceres Ventures, Inc.' s Revenue no change of 0% ranks overall at the positon no. in the third quarter 2012.


CEVE Revenue ( Y/Y Growth %) 2012
 2011 2010 2009
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Ceres Ventures,'s third quarter 2012 Revenue $ 0.00 millions CEVE's Income Statement
Ceres Ventures,'s third quarter 2011 Revenue $ 0.00 millions Quarterly CEVE's Income Statement


CEVE Revenue (Quarter on Quarter Growth %)

 2012
 2011 2010 2009
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Back to CEVE Growth rate Comparisons >> Back to CEVE Growth rate Comparisons >>


Revenue third quarter 2012 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2012 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2009, 2010, 2011, 2012

Ceres Ventures,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CEVE's III. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CEVE's III. Quarter Q/Q Revenue Comment


Ceres Ventures,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2012)		 12 Months Ending
(Jun 30 2012)		 12 Months Ending
(Mar 31 2012)		 12 Months Ending
(Dec 31 2011)		 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Sep 30 2012 period, Ceres Ventures,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Ceres Ventures, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2012 period, Ceres Ventures,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Ceres Ventures, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CEVE's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Sep 30 2012 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2012
Baxter International Inc -0.06%$ -0.057 millions
Exact Sciences Corporation-0.29%$ -0.289 millions
Aspira Women s Health inc -0.31%$ -0.313 millions
Quidelortho Corp-0.33%$ -0.332 millions
3m Company-0.45%$ -0.451 millions
Zimmer Biomet Holdings Inc -0.58%$ -0.582 millions
Filana Therapeutics Inc -0.87%$ -0.873 millions
Waters Corporation-1.01%$ -1.008 millions
Fonar Corporation-1.01%$ -1.010 millions
Spero Therapeutics Inc -1.04%$ -1.043 millions
Harvard Bioscience Inc -1.05%$ -1.050 millions
Alphatec Holdings Inc -1.64%$ -1.638 millions
Clearpoint Neuro Inc -2.00%$ -2.000 millions
Infusystem Holdings Inc-2.28%$ -2.275 millions
Utah Medical Products Inc-2.74%$ -2.736 millions
Quest Diagnostics Inc-2.88%$ -2.883 millions
Bio techne Corp-3.31%$ -3.313 millions
Bio rad Laboratories Inc -3.45%$ -3.449 millions
American Bio Medica Corporation-3.47%$ -3.467 millions
Msa Safety Inc-3.86%$ -3.858 millions
Heska Corporation-3.99%$ -3.987 millions
Cumberland Pharmaceuticals Inc -4.00%$ -4.003 millions
Becton Dickinson And Company-4.08%$ -4.078 millions
St Jude Medical Inc-4.09%$ -4.091 millions
Diversicare Healthcare Services Inc -4.10%$ -4.103 millions
Precipio inc -4.41%$ -4.411 millions
Merck and Co Inc -4.44%$ -4.442 millions
Vycor Medical Inc -4.82%$ -4.824 millions
Orthofix Medical Inc -5.10%$ -5.104 millions
Tenet Healthcare Corp-5.17%$ -5.167 millions


About Ceres Ventures, Revenue Growth Rates (CEVE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.